| Year |
Citation |
Score |
| 2020 |
de Jong MC, Gaze MN, Szychot E, Rozalén García V, Brain C, Dattani M, Spoudeas H, Hindmarsh P, Abdel-Aziz TE, Bomanji J, Shankar A, Stoneham S, Morley S, Beale T, Jawad S, et al. Treating papillary and follicular thyroid cancer in children and young people: Single UK-center experience between 2003 and 2018. Journal of Pediatric Surgery. PMID 32838975 DOI: 10.1016/J.Jpedsurg.2020.07.034 |
0.34 |
|
| 2020 |
Melin J, Parra-Guillen ZP, Michelet R, Truong T, Huisinga W, Hartung N, Hindmarsh P, Kloft C. Pharmacokinetic/pharmacodynamic evaluation of hydrocortisone therapy in pediatric patients with congenital adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism. PMID 32052005 DOI: 10.1210/Clinem/Dgaa071 |
0.332 |
|
| 2019 |
Kayemba-Kay's S, Maillet O, Hindmarsh P, Heron A. Growth screening in children aged 3-5 years: a useful tool for public health programs in community pediatrics. Journal of Pediatric Endocrinology & Metabolism : Jpem. PMID 31216265 DOI: 10.1515/Jpem-2018-0545 |
0.425 |
|
| 2015 |
Waelchi R, Williams J, Cole T, Dattani M, Hindmarsh P, Kennedy H, Martinez A, Khan S, Semple R, White A, Sebire N, Healy E, Moore G, Kinsler V. Growth and hormonal profiling in children with congenital melanocytic naevi. The British Journal of Dermatology. PMID 26286459 DOI: 10.1111/Bjd.14091 |
0.468 |
|
| 2015 |
Cole TJ, Ahmed ML, Preece MA, Hindmarsh P, Dunger DB. The relationship between Insulin-like Growth Factor 1, sex steroids and timing of the pubertal growth spurt. Clinical Endocrinology. 82: 862-9. PMID 25418044 DOI: 10.1111/Cen.12682 |
0.433 |
|
| 2015 |
Hindmarsh PC, Charmandari E. Variation in absorption and half-life of hydrocortisone influence plasma cortisol concentrations. Clinical Endocrinology. 82: 557-61. PMID 25369980 DOI: 10.1111/Cen.12653 |
0.532 |
|
| 2015 |
Sinha CK, Decoppi P, Pierro A, Brain C, Hindmarsh P, Butler G, Dattani M, Spoudeas H, Kurzawinski TR. Thyroid Surgery in Children: Clinical Outcomes. European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [Et Al] = Zeitschrift Fur Kinderchirurgie. 25: 425-9. PMID 25144354 DOI: 10.1055/S-0034-1384649 |
0.316 |
|
| 2014 |
Silajdžić E, Kalliolia E, Nambron R, Costelloe S, Martin N, Hill N, Frost C, Watt H, Hindmarsh P, Björkqvist M, Warner T. D04 A Study Of The Hypothalamo-pituitary Axes In Huntington’s Disease Journal of Neurology, Neurosurgery, and Psychiatry. 85. DOI: 10.1136/Jnnp-2014-309032.96 |
0.403 |
|
| 2013 |
Langham S, Hindmarsh P, Krywawych S, Peters C. Screening for congenital hypothyroidism: comparison of borderline screening cut-off points and the effect on the number of children treated with levothyroxine. European Thyroid Journal. 2: 180-6. PMID 24847451 DOI: 10.1159/000350039 |
0.303 |
|
| 2013 |
Peters CJ, Hill N, Dattani MT, Charmandari E, Matthews DR, Hindmarsh PC. Deconvolution analysis of 24-h serum cortisol profiles informs the amount and distribution of hydrocortisone replacement therapy. Clinical Endocrinology. 78: 347-51. PMID 22803584 DOI: 10.1111/J.1365-2265.2012.04502.X |
0.581 |
|
| 2011 |
Pasterski V, Geffner ME, Brain C, Hindmarsh P, Brook C, Hines M. Prenatal hormones and childhood sex segregation: playmate and play style preferences in girls with congenital adrenal hyperplasia. Hormones and Behavior. 59: 549-55. PMID 21338606 DOI: 10.1016/J.Yhbeh.2011.02.007 |
0.687 |
|
| 2011 |
Knowles RL, Oerton JM, Khalid JM, Hindmarsh P, Kelnar C, Dezateux C. Clinical outcome of congenital adrenal hyperplasia (CAH) one year following diagnosis: a UK wide study Archives of Disease in Childhood. 96: A27-A27. DOI: 10.1136/Adc.2011.212563.54 |
0.411 |
|
| 2010 |
Knowles R, Khalid J, Oerton J, Hindmarsh P, Kelnar C, Dezateux C. Clinical presentation of older children with congenital adrenal hyperplasia: an important outcome for newborn screening policy Archives of Disease in Childhood. 95: A6.3-A7. DOI: 10.1136/Adc.2010.186338.16 |
0.386 |
|
| 2009 |
Collaer ML, Brook CG, Conway GS, Hindmarsh PC, Hines M. Motor development in individuals with congenital adrenal hyperplasia: strength, targeting, and fine motor skill. Psychoneuroendocrinology. 34: 249-58. PMID 18938041 DOI: 10.1016/J.Psyneuen.2008.09.007 |
0.629 |
|
| 2008 |
Danne T, Battelino T, Jarosz-Chobot P, Kordonouri O, Pánkowska E, Ludvigsson J, Schober E, Kaprio E, Saukkonen T, Nicolino M, Tubiana-Rufi N, Klinkert C, Haberland H, Vazeou A, Madacsy L, ... ... Hindmarsh P, et al. Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries. Diabetologia. 51: 1594-601. PMID 18592209 DOI: 10.1007/S00125-008-1072-2 |
0.301 |
|
| 2008 |
Elder CJ, Barton JS, Brook CG, Preece MA, Dattani MT, Hindmarsh PC. A randomised study of the effect of two doses of biosynthetic human growth hormone on final height of children with familial short stature. Hormone Research. 70: 89-92. PMID 18547955 DOI: 10.1159/000139150 |
0.699 |
|
| 2008 |
Coelho R, Brook CG, Preece MA, Stanhope RG, Dattani MT, Hindmarsh PC. A randomised study of two doses of biosynthetic human growth hormone on final height of pubertal children with growth hormone deficiency. Hormone Research. 70: 85-8. PMID 18547954 DOI: 10.1159/000139149 |
0.733 |
|
| 2007 |
Pasterski V, Hindmarsh P, Geffner M, Brook C, Brain C, Hines M. Increased aggression and activity level in 3- to 11-year-old girls with congenital adrenal hyperplasia (CAH). Hormones and Behavior. 52: 368-74. PMID 17673215 DOI: 10.1016/J.Yhbeh.2007.05.015 |
0.679 |
|
| 2007 |
Abeyagunawardena AS, Hindmarsh P, Trompeter RS. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome. Archives of Disease in Childhood. 92: 585-8. PMID 17284479 DOI: 10.1136/Adc.2006.108985 |
0.393 |
|
| 2006 |
Hindmarsh PC, Dattani MT. Use of growth hormone in children. Nature Clinical Practice. Endocrinology & Metabolism. 2: 260-8. PMID 16932297 DOI: 10.1038/ncpendmet0169 |
0.328 |
|
| 2005 |
Mehta A, Hindmarsh PC, Stanhope RG, Turton JP, Cole TJ, Preece MA, Dattani MT. The role of growth hormone in determining birth size and early postnatal growth, using congenital growth hormone deficiency (GHD) as a model. Clinical Endocrinology. 63: 223-31. PMID 16060918 DOI: 10.1111/j.1365-2265.2005.02330.x |
0.31 |
|
| 2005 |
Pasterski VL, Geffner ME, Brain C, Hindmarsh P, Brook C, Hines M. Prenatal hormones and postnatal socialization by parents as determinants of male-typical toy play in girls with congenital adrenal hyperplasia. Child Development. 76: 264-78. PMID 15693771 DOI: 10.1111/j.1467-8624.2005.00843.x |
0.665 |
|
| 2004 |
Charmandari E, Brook CG, Hindmarsh PC. Classic congenital adrenal hyperplasia and puberty. European Journal of Endocrinology. 151: U77-82. PMID 15554890 DOI: 10.1530/Eje.0.151U077 |
0.77 |
|
| 2004 |
Cole TJ, Hindmarsh PC, Dunger DB. Growth hormone (GH) provocation tests and the response to GH treatment in GH deficiency. Archives of Disease in Childhood. 89: 1024-7. PMID 15499055 DOI: 10.1136/adc.2003.043406 |
0.356 |
|
| 2004 |
Hindmarsh PC. Standard and low-dose IGF-1 generation tests and spontaneous growth hormone secretion in children with idiopathic short stature Clinical Endocrinology. 60: 161-162. DOI: 10.1111/j.1365-2265.2004.01958.x |
0.36 |
|
| 2004 |
Alexander SD, Hindmarsh P. The evaluation and management of tall stature Current Paediatrics. 14: 414-421. DOI: 10.1016/J.Cupe.2004.05.005 |
0.397 |
|
| 2003 |
Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CGD, Hindmarsh PC. Sexual dimorphism in the synchrony of joint growth hormone and cortisol dynamics in children with classic 21-hydroxylase deficiency Journal of Pediatric Endocrinology and Metabolism. 16: 1119-1130. PMID 14594172 DOI: 10.1515/Jpem.2003.16.8.1119 |
0.601 |
|
| 2003 |
Hussain K, Hindmarsh P, Aynsley-Green A. Neonates with symptomatic hyperinsulinemic hypoglycemia generate inappropriately low serum cortisol counterregulatory hormonal responses The Journal of Clinical Endocrinology and Metabolism. 88: 4342-4347. PMID 12970308 DOI: 10.1210/Jc.2003-030135 |
0.375 |
|
| 2003 |
Hussain K, Hindmarsh P, Aynsley-Green A. Spontaneous Hypoglycemia in Childhood Is Accompanied by Paradoxically Low Serum Growth Hormone and Appropriate Cortisol Counterregulatory Hormonal Responses The Journal of Clinical Endocrinology and Metabolism. 88: 3715-3723. PMID 12915660 DOI: 10.1210/Jc.2003-030137 |
0.305 |
|
| 2003 |
Roche EF, Charmandari E, Dattani MT, Hindmarsh PC. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report. Clinical Endocrinology. 58: 589-96. PMID 12699440 DOI: 10.1046/J.1365-2265.2003.01757.X |
0.571 |
|
| 2002 |
Charmandari E, Johnston A, Honour JW, Brook CG, Hindmarsh PC. Treatment with flutamide decreases cortisol clearance: implications for therapy in congenital adrenal hyperplasia. Journal of Pediatric Endocrinology & Metabolism : Jpem. 15: 435-9. PMID 12008691 DOI: 10.1515/Jpem.2002.15.4.435 |
0.748 |
|
| 2002 |
Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CG, Hindmarsh PC. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion. The Journal of Clinical Endocrinology and Metabolism. 87: 2238-44. PMID 11994370 DOI: 10.1210/Jcem.87.5.8503 |
0.788 |
|
| 2002 |
Fall CH, Dennison E, Cooper C, Pringle J, Kellingray SD, Hindmarsh P. Does birth weight predict adult serum cortisol concentrations? Twenty-four-hour profiles in the United kingdom 1920-1930 Hertfordshire Birth Cohort. The Journal of Clinical Endocrinology and Metabolism. 87: 2001-7. PMID 11994332 DOI: 10.1210/Jcem.87.5.8469 |
0.32 |
|
| 2002 |
Charmandari E, Brook CG, Hindmarsh PC. Why is management of patients with classical congenital adrenal hyperplasia more difficult at puberty? Archives of Disease in Childhood. 86: 266-9. PMID 11919101 DOI: 10.1136/Adc.86.4.266 |
0.757 |
|
| 2002 |
Charmandari E, Dattani MT, Perry LA, Hindmarsh PC, Brook CG. Kinetics and effect of percutaneous administration of dihydrotestosterone in children. Hormone Research. 56: 177-81. PMID 11910204 DOI: 10.1159/000048115 |
0.754 |
|
| 2002 |
Mehta A, Hindmarsh PC. The use of somatropin (recombinant growth hormone) in children of short stature. Paediatric Drugs. 4: 37-47. PMID 11817985 DOI: 10.2165/00128072-200204010-00005 |
0.334 |
|
| 2001 |
Bahadur G, Hindmarsh P, Ralph D. Fertility preservation in children--scientific advances, research dilemmas, and ethics of consent. Archives of Disease in Childhood. 85: 442-442. PMID 11676434 DOI: 10.1136/Adc.85.5.442C |
0.309 |
|
| 2001 |
Charmandari E, Matthews DR, Johnston A, Brook CGD, Hindmarsh PC. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: Is current replacement therapy satisfactory? Journal of Clinical Endocrinology and Metabolism. 86: 4679-4685. PMID 11600525 DOI: 10.1210/Jcem.86.10.7972 |
0.582 |
|
| 2001 |
Charmandari E, Pincus SM, Matthews DR, Dennison E, Fall CHD, Hindmarsh PC. Joint growth hormone and cortisol spontaneous secretion is more asynchronous in older females than in their male counterparts Journal of Clinical Endocrinology and Metabolism. 86: 3393-3399. PMID 11443216 DOI: 10.1210/Jcem.86.7.7695 |
0.6 |
|
| 2001 |
Charmandari E, Lichtarowicz-Krynska EJ, Hindmarsh PC, Johnston A, Aynsley-Green A, Brook CG. Congenital adrenal hyperplasia: management during critical illness. Archives of Disease in Childhood. 85: 26-8. PMID 11420193 DOI: 10.1136/Adc.85.1.26 |
0.53 |
|
| 2001 |
Charmandari E, Hindmarsh PC, Johnston A, Brook CG. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty. The Journal of Clinical Endocrinology and Metabolism. 86: 2701-8. PMID 11397874 DOI: 10.1210/Jcem.86.6.7522 |
0.75 |
|
| 2001 |
Charmandari E, Johnston A, Brook CG, Hindmarsh PC. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. The Journal of Endocrinology. 169: 65-70. PMID 11250647 DOI: 10.1677/Joe.0.1690065 |
0.55 |
|
| 2000 |
Monson JP, Hindmarsh P. The assessment of growth hormone deficiency in children and adults with particular reference to the transitional period. Clinical Endocrinology. 53: 545-547. PMID 11106913 DOI: 10.1046/J.1365-2265.2000.01043.X |
0.426 |
|
| 2000 |
Fall CH, Clark PM, Hindmarsh PC, Clayton PE, Shiell AW, Law CM. Urinary GH and IGF-I excretion in nine year-old children: relation to sex, current size and size at birth. Clinical Endocrinology. 53: 69-76. PMID 10931082 DOI: 10.1046/j.1365-2265.2000.01047.x |
0.302 |
|
| 2000 |
Koziell A, Charmandari E, Hindmarsh PC, Rees L, Scambler P, Brook CG. Frasier syndrome, part of the Denys Drash continuum or simply a WT1 gene associated disorder of intersex and nephropathy? Clinical Endocrinology. 52: 519-24. PMID 10762296 DOI: 10.1046/J.1365-2265.2000.052006801.X |
0.499 |
|
| 1999 |
Achermann JC, Hindmarsh PC, Robinson IC, Matthews DR, Brook CG. The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2) and intermittent somatostatin(1-14)(SS) in growth hormone (GH) pulse generation: studies in normal and post cranial irradiated individuals. Clinical Endocrinology. 51: 575-85. PMID 10594518 DOI: 10.1046/j.1365-2265.1999.00839.x |
0.33 |
|
| 1999 |
Geary M, Pringle PJ, Persaud M, Wilshin J, Hindmarsh PC, Rodeck CH, Brook CG. Leptin concentrations in maternal serum and cord blood: relationship to maternal anthropometry and fetal growth. British Journal of Obstetrics and Gynaecology. 106: 1054-60. PMID 10519431 DOI: 10.1111/J.1471-0528.1999.Tb08113.X |
0.638 |
|
| 1999 |
Raza J, Hindmarsh PC, Brook CG. Thyrotoxicosis in children: thirty years' experience. Acta Paediatrica (Oslo, Norway : 1992). 88: 937-41. PMID 10519332 DOI: 10.1080/08035259950168405 |
0.665 |
|
| 1999 |
Achermann JC, Brook CG, Robinson IC, Matthews DR, Hindmarsh PC. Peak and trough growth hormone (GH) concentrations influence growth and serum insulin like growth factor-1 (IGF-1) concentrations in short children. Clinical Endocrinology. 50: 301-8. PMID 10435054 DOI: 10.1111/j.1365-2265.1999.tb03945.x |
0.336 |
|
| 1999 |
Tiulpakov AN, Mazerkina NA, Brook CG, Hindmarsh PC, Peterkova VA, Gorelyshev SK. Growth in children with craniopharyngioma following surgery. Clinical Endocrinology. 49: 733-8. PMID 10209560 DOI: 10.1046/j.1365-2265.1998.00590.x |
0.309 |
|
| 1999 |
Ramaswami U, Hindmarsh PC, Brook CG. Growth hormone therapy in hypochondroplasia. Acta Paediatrica (Oslo, Norway : 1992). Supplement. 88: 116-7. PMID 10102069 DOI: 10.1111/j.1651-2227.1999.tb14368.x |
0.355 |
|
| 1999 |
Wilshin J, Geary M, Persaud M, Hindmarsh P. The reliability of newborn length measurement British Journal of Midwifery. 7: 236-239. DOI: 10.12968/Bjom.1999.7.4.8349 |
0.313 |
|
| 1998 |
Achermann JC, Hamdani K, Hindmarsh PC, Brook CG. Birth weight influences the initial response to growth hormone treatment in growth hormone-insufficient children. Pediatrics. 102: 342-5. PMID 9685436 DOI: 10.1542/Peds.102.2.342 |
0.723 |
|
| 1998 |
Ramaswami U, Rumsby G, Hindmarsh PC, Brook CG. Genotype and phenotype in hypochondroplasia. The Journal of Pediatrics. 133: 99-102. PMID 9672519 DOI: 10.1016/S0022-3476(98)70186-6 |
0.658 |
|
| 1998 |
Cornean RE, Hindmarsh PC, Brook CG. Obesity in 21-hydroxylase deficient patients. Archives of Disease in Childhood. 78: 261-3. PMID 9613359 DOI: 10.1136/Adc.78.3.261 |
0.645 |
|
| 1998 |
Raza J, Hindmarsh PC, Brook CG. Factors involved in the rate of fall of thyroid stimulating hormone in treated hypothyroidism. Archives of Disease in Childhood. 77: 526-7. PMID 9496191 DOI: 10.1136/Adc.77.6.526 |
0.684 |
|
| 1998 |
Fall C, Hindmarsh P, Dennison E, Kellingray S, Barker D, Cooper C. Programming of growth hormone secretion and bone mineral density in elderly men: a hypothesis. The Journal of Clinical Endocrinology and Metabolism. 83: 135-9. PMID 9435430 DOI: 10.1210/Jcem.83.1.4487 |
0.345 |
|
| 1998 |
Massoud AF, Hindmarsh PC, Brook CG. Interaction of the growth hormone releasing peptide hexarelin with somatostatin. Clinical Endocrinology. 47: 537-47. PMID 9425393 DOI: 10.1046/J.1365-2265.1997.3121128.X |
0.693 |
|
| 1997 |
Massoud AF, Powell M, Williams RA, Hindmarsh PC, Brook CG. Transsphenoidal surgery for pituitary tumours. Archives of Disease in Childhood. 76: 398-404. PMID 9196353 DOI: 10.1136/Adc.76.5.398 |
0.644 |
|
| 1997 |
Massoud AF, Hindmarsh PC, Brook CG. Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study. The Journal of Clinical Endocrinology and Metabolism. 81: 4338-41. PMID 8954038 DOI: 10.1210/Jcem.81.12.8954038 |
0.667 |
|
| 1996 |
Dattani MT, Winrow AP, Tuil'Pakov A, Pringle PJ, Hindmarsh PC, Brook CGD, Marshall NJ. Evaluation of growth hormone (GH) responses to pulsed GH-releasing hormone administration using the MTT-ESTA bioassay European Journal of Endocrinology. 135: 87-95. PMID 8765979 DOI: 10.1530/EJE.0.1350087 |
0.321 |
|
| 1996 |
Massoud AF, Hindmarsh PC, Matthews DR, Brook CGD. The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity Clinical Endocrinology. 44: 555-562. PMID 8762732 DOI: 10.1046/J.1365-2265.1996.722543.X |
0.325 |
|
| 1996 |
Hindmarsh PC, Brook CG. Final height of short normal children treated with growth hormone. Lancet (London, England). 348: 13-6. PMID 8691923 DOI: 10.1016/S0140-6736(96)01038-0 |
0.724 |
|
| 1996 |
Cao Y, Wagner JK, Hindmarsh PC, Eblé A, Mullis PE. Isolated growth hormone deficiency: testing the little mouse hypothesis in man and exclusion of mutations within the extracellular domain of the growth hormone-releasing hormone receptor. Pediatric Research. 38: 962-6. PMID 8618801 DOI: 10.1203/00006450-199512000-00022 |
0.302 |
|
| 1996 |
Massoud AF, Hindmarsh PC, Brook CG. Hexarelin induced growth hormone release is influenced by exogenous growth hormone. Clinical Endocrinology. 43: 617-21. PMID 8548947 DOI: 10.1111/J.1365-2265.1995.Tb02927.X |
0.695 |
|
| 1996 |
Smith SL, Hindmarsh PC, Brook CG. Compliance with growth hormone treatment--are they getting it? Archives of Disease in Childhood. 73: 277. PMID 7492183 DOI: 10.1136/adc.73.3.277-a |
0.307 |
|
| 1995 |
Crowley S, Hindmarsh PC, Matthews DR, Brook CGD. Growth and the growth hormone axis in prepubertal children with asthma The Journal of Pediatrics. 126: 297-303. PMID 7844682 DOI: 10.1016/S0022-3476(95)70566-X |
0.365 |
|
| 1995 |
Hindmarsh PC, Pringle PJ, Stanhope R, Brook CG. The effect of a continuous infusion of a somatostatin analogue (octreotide) for two years on growth hormone secretion and height prediction in tall children. Clinical Endocrinology. 42: 509-15. PMID 7621570 DOI: 10.1111/j.1365-2265.1995.tb02670.x |
0.384 |
|
| 1995 |
Hindmarsh PC, Brook CG. Short stature and growth hormone deficiency. Clinical Endocrinology. 43: 133-42. PMID 7554307 DOI: 10.1111/j.1365-2265.1995.tb01907.x |
0.323 |
|
| 1995 |
Fall C, Hindmarsh P, Egger P, Eastell R, Cooper C. 24-hour growth hormone profiles and bone density in elderly men Bone. 17: 323. DOI: 10.1016/8756-3282(95)97367-O |
0.315 |
|
| 1994 |
Allen DB, Brook CG, Bridges NA, Hindmarsh PC, Guyda HJ, Frazier D. Therapeutic controversies: growth hormone (GH) treatment of non-GH deficient subjects. The Journal of Clinical Endocrinology and Metabolism. 79: 1239-48. PMID 7962315 DOI: 10.1210/JCEM.79.5.7962315 |
0.696 |
|
| 1993 |
Ryalls M, Spoudeas HA, Hindmarsh PC, Matthews DR, Tait DM, Meller ST, Brook CG. Short-term endocrine consequences of total body irradiation and bone marrow transplantation in children treated for leukemia. The Journal of Endocrinology. 136: 331-8. PMID 8459199 DOI: 10.1677/JOE.0.1360331 |
0.322 |
|
| 1993 |
Barton JS, Hindmarsh PC, Preece MA, Brook CG. Blood pressure and the renin-angiotensin-aldosterone system in children receiving recombinant human growth hormone. Clinical Endocrinology. 38: 245-51. PMID 8458096 DOI: 10.1111/j.1365-2265.1993.tb01002.x |
0.341 |
|
| 1993 |
Brain C, Thakrar DN, Hindmarsh PC, Brook CG. Physiological levels of growth hormone fail to suppress growth hormone releasing hormone (1-29) NH2-stimulated growth hormone secretion in man. Journal of Endocrinological Investigation. 16: 15-20. PMID 8445152 DOI: 10.1007/BF03345822 |
0.314 |
|
| 1993 |
Crowley S, Hindmarsh PC, Honour JW, Brook CG. Reproducibility of the cortisol response to stimulation with a low dose of ACTH(1-24): the effect of basal cortisol levels and comparison of low-dose with high-dose secretory dynamics. The Journal of Endocrinology. 136: 167-72. PMID 8429271 DOI: 10.1677/JOE.0.1360167 |
0.65 |
|
| 1993 |
Hakeem V, Hindmarsh PC, Brook CG. Intermittent versus continuous administration of growth hormone treatment. Archives of Disease in Childhood. 68: 783-4. PMID 8333773 DOI: 10.1136/ADC.68.6.783 |
0.37 |
|
| 1993 |
Malhotra A, Poon E, Tse WY, Pringle PJ, Hindmarsh PC, Brook CG. The effects of oxandrolone on the growth hormone and gonadal axes in boys with constitutional delay of growth and puberty. Clinical Endocrinology. 38: 393-8. PMID 8319371 DOI: 10.1111/j.1365-2265.1993.tb00520.x |
0.332 |
|
| 1993 |
Stanhope R, Albanese A, Hindmarsh P, Brook CG. The effects of growth hormone therapy on spontaneous sexual development. Hormone Research. 9-13. PMID 1295821 DOI: 10.1159/000182563 |
0.729 |
|
| 1993 |
Hakeem VF, Hindmarsh PC, Stanhope R, Brook CGD. SHOULD GROWTH HORMONE DOSES BE INCREASED DURING PUBERTY? Pediatric Research. 33: S37-S37. DOI: 10.1203/00006450-199305001-00202 |
0.305 |
|
| 1993 |
Hindmarsh PC, Pringle PJ, Stanhope R. EFFECT OF A CONTINUOUS INFUSION OF A SOMATOSTATIN ANALOGUE ON GROWTH RATE, GROWTH HORMONE SECRETION AND HEIGHT PREDICTION IN TALL CHILDREN Pediatric Research. 33: S36-S36. DOI: 10.1203/00006450-199305001-00199 |
0.346 |
|
| 1993 |
Spoudeas HA, Hindmarsh PC, Matthews DR. DISCREPANCIES BETWEEN PHYSIOLOGICAL AND PHARMACOLOGICAL TESTS OF GROWTH HORMONE (GH) SECRETION IN CHILDREN WITH BRAIN TUMOURS (BT) Pediatric Research. 33: S27-S27. DOI: 10.1203/00006450-199305001-00142 |
0.335 |
|
| 1993 |
Bridges NA, Cooke A, Healy MJ, Hindmarsh PC, Brook CG. Standards for ovarian volume in childhood and puberty**Presented at the 12th meeting of the British Endocrine Societies, Liverpool, United Kingdom March 29 to April 1, 1992. Fertility and Sterility. 60: 456-460. DOI: 10.1016/S0015-0282(16)56160-3 |
0.693 |
|
| 1992 |
Bridges NA, Hindmarsh PC, Brook CG. Growth of children with hypochondroplasia treated with growth hormone for up to three years. Hormone Research. 56-60. PMID 1806487 DOI: 10.1159/000182190 |
0.721 |
|
| 1992 |
Dattani MT, Pringle PJ, Hindmarsh PC, Brook CG. What is a normal stimulated growth hormone concentration? The Journal of Endocrinology. 133: 447-50. PMID 1613446 DOI: 10.1677/JOE.0.1330447 |
0.356 |
|
| 1992 |
Wit JM, Massarano AA, Kamp GA, Hindmarsh PC, van Es A, Brook CG, Preece MA, Matthews DR. Growth hormone secretion in patients with Turner's syndrome as determined by time series analysis. Acta Endocrinologica. 127: 7-12. PMID 1519426 DOI: 10.1530/ACTA.0.1270007 |
0.718 |
|
| 1992 |
Hindmarsh P, Brook CG. Growth hormone and recurrence of tumour. Bmj (Clinical Research Ed.). 305: 254. PMID 1392844 DOI: 10.1136/bmj.305.6847.254 |
0.687 |
|
| 1991 |
Hindmarsh PC, Stanhope R, Preece MA, Brook CG. Frequency of administration of growth hormone--an important factor in determining growth response to exogenous growth hormone. Hormone Research. 83-9. PMID 2245975 DOI: 10.1159/000181590 |
0.706 |
|
| 1991 |
Suri D, Hindmarsh PC, Brain CE, Pringle PJ, Brook CG. The interaction between clonidine and growth hormone releasing hormone in the stimulation of growth hormone secretion in man. Clinical Endocrinology. 33: 399-406. PMID 2147600 DOI: 10.1111/j.1365-2265.1990.tb00505.x |
0.318 |
|
| 1991 |
Hindmarsh PC. Treatment of growth hormone insufficiency. Developmental Pharmacology and Therapeutics. 15: 149-52. PMID 2099896 DOI: 10.1159/000457638 |
0.388 |
|
| 1991 |
Mullis PE, Hindmarsh PC, Brook CG. Sodium chloride supplement at diagnosis and during infancy in children with salt-losing 21-hydroxylase deficiency. European Journal of Pediatrics. 150: 22-5. PMID 2079072 DOI: 10.1007/Bf01959473 |
0.667 |
|
| 1991 |
Hindmarsh PC, Bridges NA, Brook CG. Wider indications for treatment with biosynthetic human growth hormone in children. Clinical Endocrinology. 34: 417-27. PMID 2060152 DOI: 10.1111/j.1365-2265.1991.tb00315.x |
0.353 |
|
| 1991 |
Suri D, Hindmarsh PC, Matthews DR, Brain CE, Brook CGD. The pituitary gland is capable of responding to two successive doses of growth hormone releasing hormone (GHRH) Clinical Endocrinology. 34: 13-17. PMID 2004468 DOI: 10.1111/j.1365-2265.1991.tb01729.x |
0.321 |
|
| 1991 |
Trivedi P, Risteli J, Risteli L, Hindmarsh PC, Brook CG, Mowat AP. Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatric Research. 30: 276-80. PMID 1945568 DOI: 10.1203/00006450-199109000-00016 |
0.715 |
|
| 1991 |
Stanhope R, Uruena M, Hindmarsh P, Leiper AD, Brook CG. Management of growth hormone deficiency through puberty. Acta Paediatrica Scandinavica. Supplement. 372: 47-52; discussion 53. PMID 1927519 DOI: 10.1111/j.1651-2227.1991.tb17969.x |
0.365 |
|
| 1990 |
Hindmarsh PC, Matthews DR, Brain C, Pringle PJ, Brook CGD. The application of deconvolution analysis to elucidate the pulsatile nature of growth hormone secretion using a variable half-life of growth hormone Clinical Endocrinology. 32: 739-747. PMID 2383925 DOI: 10.1111/j.1365-2265.1990.tb00920.x |
0.331 |
|
| 1990 |
Darendeliler F, Hindmarsh PC, Brook CG. Dose-response curves for treatment with biosynthetic human growth hormone. The Journal of Endocrinology. 125: 311-6. PMID 2373980 DOI: 10.1677/JOE.0.1250311 |
0.306 |
|
| 1990 |
Buyukgebiz A, Hindmarsh PC, Brook CG. Treatment of constitutional delay of growth and puberty with oxandrolone compared with growth hormone. Archives of Disease in Childhood. 65: 448-9. PMID 2346341 DOI: 10.1136/adc.65.4.448 |
0.306 |
|
| 1990 |
Darendeliler F, Hindmarsh PC, Preece MA, Cox L, Brook CG. Growth hormone increases rate of pubertal maturation. Acta Endocrinologica. 122: 414-6. PMID 2327220 DOI: 10.1530/ACTA.0.1220414 |
0.347 |
|
| 1990 |
Darendeliler F, Livesey EA, Hindmarsh PC, Brook CG. Growth and growth hormone secretion in children following treatment of brain tumours with radiotherapy. Acta Paediatrica Scandinavica. 79: 950-6. PMID 2264467 DOI: 10.1111/j.1651-2227.1990.tb11357.x |
0.329 |
|
| 1990 |
Appan S, Laurent S, Chapman M, Hindmarsh PC, Brook CG. Growth and growth hormone therapy in hypochondroplasia. Acta Paediatrica Scandinavica. 79: 796-803. PMID 2239275 DOI: 10.1111/j.1651-2227.1990.tb11557.x |
0.382 |
|
| 1990 |
Darendeliler F, Hindmarsh PC, Brook CG. Non-conventional use of growth hormone: European experience. Hormone Research. 33: 128-36. PMID 2210617 DOI: 10.1159/000181496 |
0.33 |
|
| 1990 |
Brain CE, Hindmarsh PC, Brook CG. Continuous subcutaneous GHRH(1-29)NH2 promotes growth over 1 year in short, slowly growing children. Clinical Endocrinology. 32: 153-63. PMID 2140733 DOI: 10.1111/j.1365-2265.1990.tb00851.x |
0.367 |
|
| 1990 |
Livesey EA, Hindmarsh PC, Brook CG, Whitton AC, Bloom HJ, Tobias JS, Godlee JN, Britton J. Endocrine disorders following treatment of childhood brain tumours. British Journal of Cancer. 61: 622-5. PMID 2109998 DOI: 10.1038/bjc.1990.138 |
0.717 |
|
| 1989 |
Hindmarsh PC, Pringle PJ, Brook CG. Cholinergic muscarinic blockade produces short-term suppression of growth hormone secretion in children with tall stature. Clinical Endocrinology. 29: 289-96. PMID 3251668 DOI: 10.1111/j.1365-2265.1988.tb01227.x |
0.383 |
|
| 1989 |
Kirk JM, Di Silvio L, Hindmarsh PC, Brook CG. Somatostatin analogue in short term management of hyperinsulinism. Archives of Disease in Childhood. 63: 1493-4. PMID 3232999 DOI: 10.1136/Adc.63.12.1493 |
0.618 |
|
| 1989 |
Brook CG, Hindmarsh PC, Stanhope R. Growth and growth hormone secretion. The Journal of Endocrinology. 119: 179-84. PMID 3058853 DOI: 10.1677/joe.0.1190179 |
0.323 |
|
| 1989 |
Trivedi P, Hindmarsh P, Risteli J, Risteli L, Mowat AP, Brook CG. Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen. The Journal of Pediatrics. 114: 225-30. PMID 2915282 DOI: 10.1016/S0022-3476(89)80787-5 |
0.375 |
|
| 1989 |
Massarano AA, Brook CG, Hindmarsh PC, Pringle PJ, Teale JD, Stanhope R, Preece MA. Growth hormone secretion in Turner's syndrome and influence of oxandrolone and ethinyl oestradiol. Archives of Disease in Childhood. 64: 587-92. PMID 2751332 DOI: 10.1136/adc.64.4.587 |
0.351 |
|
| 1989 |
Brain C, Hindmarsh PC, Pringle PJ, Brook CG. Use of continuous subcutaneous growth hormone-releasing hormone (GHRH (1-29)NH2) infusions to augment growth hormone secretion and to promote growth. Acta Paediatrica Scandinavica. Supplement. 349: 109-13; discussion 1. PMID 2546369 DOI: 10.1111/j.1651-2227.1989.tb17180.x |
0.414 |
|
| 1988 |
Bundak R, Hindmarsh PC, Brook CG. Body segments and growth hormone. Archives of Disease in Childhood. 63: 839-40. PMID 3415304 DOI: 10.1136/adc.63.7.839 |
0.368 |
|
| 1988 |
Smith PJ, Hindmarsh PC, Brook CG. Contribution of dose and frequency of administration to the therapeutic effect of growth hormone. Archives of Disease in Childhood. 63: 491-4. PMID 3389862 DOI: 10.1136/adc.63.5.491 |
0.308 |
|
| 1988 |
Bundak R, Hindmarsh PC, Smith PJ, Brook CG. Long-term auxologic effects of human growth hormone. The Journal of Pediatrics. 112: 875-9. PMID 3373391 DOI: 10.1016/S0022-3476(88)80207-5 |
0.334 |
|
| 1988 |
Brain C, Hindmarsh PC, Brook CGD, Matthews DR. Continuous subcutaneous growth hormone releasing factor analogue augments growth hormone secretion in normal male subjects with no desensitization of the somatotroph Clinical Endocrinology. 28: 543-549. PMID 3214946 DOI: 10.1111/j.1365-2265.1988.tb03689.x |
0.345 |
|
| 1988 |
Hindmarsh PC, Matthews DR, Brain CE, Pringle PJ, Brook CCD. 46 CALCULATION OF PITUITARY GROWTH HORMONE (GH) SECRETION RATE IN CHILDREN Pediatric Research. 24: 524-524. DOI: 10.1203/00006450-198810000-00067 |
0.368 |
|
| 1988 |
Pringle PJ, Hindmarsh PC, Di Silvio L, Smith PJ, Kurtz AB, Brook CCD. EFFECT OF GROWTH HORMONE (GH) ANTIBODIES ON THE GH CONCENTRATIONS OBTAINED AFTER ADMINISTRATION OF BIOSYNTHETIC GH TO CHILDREN Pediatric Research. 23: 118-118. DOI: 10.1203/00006450-198801000-00100 |
0.359 |
|
| 1987 |
Stanhope R, Hindmarsh P, Kendall B, Brook CG. High resolution CT scanning of the pituitary gland in growth disorders. Acta Paediatrica Scandinavica. 75: 779-86. PMID 3564946 DOI: 10.1111/j.1651-2227.1986.tb10290.x |
0.368 |
|
| 1987 |
Hindmarsh P, Smith PJ, Brook CGD, Matthews DR. The relationship between height velocity and growth hormone secretion in short prepubertal children Clinical Endocrinology. 27: 581-591. PMID 3450456 DOI: 10.1111/j.1365-2265.1987.tb01188.x |
0.33 |
|
| 1987 |
Brook CG, Hindmarsh PC, Smith PJ. Is growth hormone deficiency a useful diagnosis? Acta Paediatrica Scandinavica. Supplement. 331: 70-5. PMID 3300158 DOI: 10.1111/j.1651-2227.1987.tb17102.x |
0.349 |
|
| 1987 |
Hindmarsh PC, Brook CG. Effect of growth hormone on short normal children. British Medical Journal (Clinical Research Ed.). 295: 573-7. PMID 3117236 DOI: 10.1136/bmj.295.6598.573 |
0.354 |
|
| 1987 |
Brook CG, Jacobs HS, Stanhope R, Adams J, Hindmarsh P. Pulsatility of reproductive hormones: applications to the understanding of puberty and to the treatment of infertility. Bailliere's Clinical Endocrinology and Metabolism. 1: 23-41. PMID 3109365 DOI: 10.1016/S0950-351X(87)80051-4 |
0.674 |
|
| 1987 |
Hindmarsh PC, Stanhope R, Kendall BE, Brook CG. Tall stature: a clinical, endocrinological and radiological study. Clinical Endocrinology. 25: 223-31. PMID 3098463 DOI: 10.1111/j.1365-2265.1986.tb01686.x |
0.364 |
|
| 1987 |
Brook CGD, Hindmarsh P. Effect of growth hormone on short normal children:: Authors' reply Bmj. 295: 1063-1063. DOI: 10.1136/Bmj.295.6605.1063-B |
0.472 |
|
| 1984 |
Hindmarsh P, Brook CG. Assessment of growth in short children. The Journal of Pediatrics. 105: 855-6. PMID 6502329 DOI: 10.1016/S0022-3476(84)80342-X |
0.709 |
|
| Show low-probability matches. |
